SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-029223
Filing Date
2021-11-18
Accepted
2021-11-18 16:05:32
Documents
13
Period of Report
2021-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41627
2 ex3-1.htm EX-3.1 7558
  Complete submission text file 0001493152-21-029223.txt   229374

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE envb-20211115.xsd EX-101.SCH 3020
4 XBRL LABEL FILE envb-20211115_lab.xml EX-101.LAB 34238
5 XBRL PRESENTATION FILE envb-20211115_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3856
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 211424433
SIC: 2834 Pharmaceutical Preparations